Literature DB >> 2622763

The effect of long-term administration of alpha 1-blocker prazosin on capillary density in cardiac and skeletal muscle.

A Ziada1, O Hudlicka, K R Tyler.   

Abstract

The effect of prazosin on heart and muscle blood flow and capillary density was studied in rats. In acute experiments, alpha 1-blocker prazosin almost trebled blood flow in fast skeletal muscles [tibialis anterior (TA) and extensor digitorum longus (EDL)], but did not affect coronary flow when infused i.v. at a dose of 0.5 microgram.ml-1.min-1 for 30 min. Prazosin in an equivalent dose was then given orally over a period of 5 weeks to investigate its effect on capillarisation in heart and skeletal muscle. Capillary density (CD, capillaries.mm-2), estimated in frozen sections stained for alkaline phosphatase, was similar in the hearts of prazosin-treated and control rats. Capillary/fibre ratio in skeletal muscles increased from 1.52 +/- 0.019 in control EDL to 1.69 +/- 0.01 (P less than 0.001) and from 1.56 +/- 0.04 in control TA to 2.16 +/- 0.04 (P less than 0.001). In TA, the increase was greater than in EDL both in the glycolytic periphery (from 1.30 +/- 0.13 to 1.75 +/- 0.11, P less than 0.025) and the oxidative core of the muscle (from 1.837 +/- 0.14 to 2.51 +/- 0.12, P less than 0.005). Unilateral crush of the lateral peroneal nerve and subsequent reinnervation over the next 7 weeks resulted in redistribution of fibre types from a typical mosaic pattern into groups composed of fibres of similar oxidative capacity. Capillary density as well as capillary/fibre ratio in purely glycolytic areas was lower when compared to supply of glycolytic fibres in normal muscles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2622763     DOI: 10.1007/bf00370888

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  32 in total

1.  Relationship between the size of the capillary bed and oxidative capacity in various cat skeletal muscles.

Authors:  O Hudlicka; H Hoppeler; E Uhlmann
Journal:  Pflugers Arch       Date:  1987-11       Impact factor: 3.657

2.  Long-term isoprenaline administration produces an increase in capillarity in the soleus muscle of the rat.

Authors:  A H Sillau; M de L Philippi
Journal:  Can J Physiol Pharmacol       Date:  1987-03       Impact factor: 2.273

3.  Capillary neoformation in the heart and skeletal muscle during dipyridamole--treatment and exercise.

Authors:  G Tornling
Journal:  Acta Pathol Microbiol Immunol Scand Suppl       Date:  1982

4.  Capillary growth and changes in heart performance induced by chronic bradycardial pacing in the rabbit.

Authors:  A J Wright; O Hudlicka
Journal:  Circ Res       Date:  1981-08       Impact factor: 17.367

5.  How to quantify skeletal muscle capillarity.

Authors:  J T Loats; A H Sillau; N Banchero
Journal:  Adv Exp Med Biol       Date:  1977 Jul 4-7       Impact factor: 2.622

6.  Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.

Authors:  D A Carson; J E Seegmiller
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats.

Authors:  D J Sheridan; P A Penkoske; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

8.  Capillary tortuosity in rat soleus muscle is not affected by endurance training.

Authors:  D C Poole; O Mathieu-Costello; J B West
Journal:  Am J Physiol       Date:  1989-04

9.  Is dipyridamole an angiogenic agent?

Authors:  W Jakob; J Zipper; S B Sávoly; W E Siems; K D Jentzsch
Journal:  Exp Pathol       Date:  1982

10.  The metabolic fate of prazosin.

Authors:  J A Taylor; T M Twomey; M S von Wittenau
Journal:  Xenobiotica       Date:  1977-06       Impact factor: 1.908

View more
  11 in total

1.  The role of blood flow and/or muscle hypoxia in capillary growth in chronically stimulated fast muscles.

Authors:  O Hudlicka; S Price
Journal:  Pflugers Arch       Date:  1990-09       Impact factor: 3.657

Review 2.  What makes blood vessels grow?

Authors:  O Hudlicka
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

3.  Metabolic effects of prazosin on skeletal muscle insulin resistance in glucocorticoid-treated male rats.

Authors:  Emily C Dunford; Erin R Mandel; Sepideh Mohajeri; Tara L Haas; Michael C Riddell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-09       Impact factor: 3.619

4.  p38 MAPK activity is stimulated by vascular endothelial growth factor receptor 2 activation and is essential for shear stress-induced angiogenesis.

Authors:  Eric Gee; Malgorzata Milkiewicz; Tara L Haas
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

5.  Can changes in microcirculation explain capillary growth in skeletal muscle?

Authors:  J M Dawson; O Hudlicka
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

6.  The relationship between capillarisation and fibre types during compensatory hypertrophy of the plantaris muscle in the rat.

Authors:  H Degens; Z Turek; L J Hoofd; M A Van't Hof; R A Binkhorst
Journal:  J Anat       Date:  1992-06       Impact factor: 2.610

7.  Role of adrenergic receptors in vascular remodelling of the rat choroid.

Authors:  Jena J Steinle; Peter G Smith
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

8.  The effects of voluntary exercise and prazosin on capillary rarefaction and metabolism in streptozotocin-induced diabetic male rats.

Authors:  Emily C Dunford; Erwan Leclair; Julian Aiken; Erin R Mandel; Tara L Haas; Olivier Birot; Michael C Riddell
Journal:  J Appl Physiol (1985)       Date:  2016-12-08

9.  Factors involved in capillary growth in the heart.

Authors:  O Hudlická; M D Brown; H Walter; J B Weiss; A Bate
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

10.  Prazosin Can Prevent Glucocorticoid Mediated Capillary Rarefaction.

Authors:  Erin R Mandel; Emily C Dunford; Anastassia Trifonova; Ghoncheh Abdifarkosh; Trevor Teich; Michael C Riddell; Tara L Haas
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.